Autopsy report · NCT00020969
Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
Cause of deathNo reason given
Life of this trial
- Registered 4 months after it had already started.
- Ran for about 3 years 10 months before it stopped.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- CTI BioPharma
- Sponsor type
- Industry
- Conditions
- Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms
- Interventions
- arsenic trioxide
- Sites
- 8
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.